Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population. (February 2014)

• Record Type: Journal Article
• Authors: Cai, Qian; Buono, Jessica L.; Spalding, William M.; Sarocco, Phil; Tan, Hiangkiat; Stephenson, Judith J.; Carson, Robyn T.; Doshi, Jalpa A.
• Is Part Of: Journal of medical economics. Volume 17:Number 2(2014)
• Page Start: 148
• Page End: 158
• Publication Date: 2014-02
• Subjects: Medical care -- Cost control -- Periodicals; Medical economics -- Periodicals; 362.10941
• DOI: 10.3111/13696998.2013.860375
• Languages: English
• ISSNs: 1369-6998

Abstract

<abstract> <title>Abstract</title> <sec id="ss1"> <title>Objective:</title> <p>To evaluate total annual all-cause, gastrointestinal-related, and symptom-related healthcare costs among chronic constipation (CC) patients and estimate incremental all-cause healthcare costs of CC patients relative to matched controls.</p> </sec> <sec id="ss2"> <title>Methods:</title> <p>Patients aged ≥18 years with continuous medical and pharmacy benefit eligibility in 2010 were identified from the HealthCore Integrated Research Database. CC patients had ≥2 medical claims for constipation (ICD-9-CM code 564.0x) ≥90 days apart or ≥1 medical claim for constipation plus ≥1 constipation-related pharmacy claim ≥90 days apart, and no medical claims for irritable bowel syndrome (IBS). Sub-groups with and without abdominal symptoms were classified according to the presence/absence of abdominal pain (ICD-9-CM code 789.0x) and bloating (ICD-9-CM code 787.3x). Controls without claims for constipation, abdominal pain, bloating, or IBS or constipation-related prescriptions were randomly selected and matched 1:1 with CC patients on age, gender, health plan region, and plan type. Generalized linear models with bootstrapping evaluated incremental all-cause costs attributable to CC, adjusting for demographics and comorbidities.</p> </sec> <sec id="ss3"> <title>Results:</title> <p>Overall, 14, 854 patients (<italic>n</italic> = 7427 each in CC and control groups) were identified (mean age = 59 years; 75.4% female). Mean annual all-cause costs for CC patients were $11, 991 (2010 USD), with nearly half (44.8%) attributable to outpatient services, including physician office visits and other outpatient services (10.0% and 34.8%, respectively). GI-related costs comprised 33.7% of total all-cause costs. Symptom-related costs accounted for 10.5%, primarily driven by costs of other outpatient services (50.6%). Adjusted incremental all-cause costs associated with CC were $3508 per patient per year ($4446 for CC with abdominal symptoms; $2783 for CC without abdominal symptoms), of which 81.0% were from medical services. Incremental cost estimates may be over- or under-estimated due to classification based on claims.</p> </sec> <sec id="ss4"> <title>Conclusions:</title> <p>CC imposes a substantial burden in direct healthcare costs in a commercially insured population, mainly attributable to greater use of medical services.</p> </sec> </abstract>